These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 23102519
1. Gd complexes of diethylenetriaminepentaacetic acid conjugates of low-molecular-weight chitosan oligosaccharide as a new liver-specific MRI contrast agent. Huang Y, Cao B, Yang X, Zhang Q, Han X, Guo Z. Magn Reson Imaging; 2013 May; 31(4):604-9. PubMed ID: 23102519 [Abstract] [Full Text] [Related]
2. Chitosan oligosaccharide based Gd-DTPA complex as a potential bimodal magnetic resonance imaging contrast agent. Huang Y, Cao J, Zhang Q, Lu ZR, Hua MQ, Zhang XY, Gao H. Magn Reson Imaging; 2016 Jan; 34(1):1-7. PubMed ID: 26485295 [Abstract] [Full Text] [Related]
6. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats. Cheng JJ, Zhu J, Liu XS, He DN, Xu JR, Wu LM, Zhou J, Feng Q. Acta Radiol; 2012 Oct 01; 53(8):900-7. PubMed ID: 22919051 [Abstract] [Full Text] [Related]
9. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging. Huang Y, Boamah PO, Gong J, Zhang Q, Hua M, Ye Y. Carbohydr Polym; 2016 Jun 05; 143():288-95. PubMed ID: 27083371 [Abstract] [Full Text] [Related]
13. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Tsuda N, Okada M, Murakami T. Eur J Radiol; 2010 Jan 05; 73(1):137-42. PubMed ID: 19026502 [Abstract] [Full Text] [Related]
14. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, Tanimoto D, Higashi H, Yamashita T. J Magn Reson Imaging; 2009 Mar 05; 29(3):636-40. PubMed ID: 19243060 [Abstract] [Full Text] [Related]
15. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery]. Yuan Z, Liu SY, Xiao XS, Zhong GR, Jiang QJ. Zhonghua Yi Xue Za Zhi; 2007 Mar 13; 87(10):673-8. PubMed ID: 17553304 [Abstract] [Full Text] [Related]
16. Magnetic resonance imaging of contrast-enhanced polyelectrolyte complexes. Huang M, Huang ZL, Bilgen M, Berkland C. Nanomedicine; 2008 Mar 13; 4(1):30-40. PubMed ID: 18201943 [Abstract] [Full Text] [Related]
17. The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI. Yim H, Yang SG, Jeon YS, Park IS, Kim M, Lee DH, Bae YH, Na K. Biomaterials; 2011 Aug 13; 32(22):5187-94. PubMed ID: 21561660 [Abstract] [Full Text] [Related]
18. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium. Guo YM, Liu M, Yang JL, Guo XJ, Wang SC, Duan XY, Wang P. Chin Med J (Engl); 2007 Jan 05; 120(1):50-5. PubMed ID: 17254488 [Abstract] [Full Text] [Related]